Cardinal Capital Management Inc (North Carolina)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.45M Buy
14,151
+44
+0.3% +$24.7K 0.9% 40
2026
Q1
$7.93M Sell
14,107
-9
-0.1% -$5.77K 1.02% 34
2025
Q4
$9.55M Sell
14,116
-62
-0.4% -$42.2K 1.26% 25
2025
Q3
$9.06M Sell
14,178
-90
-0.6% -$54.6K 1.25% 25
2025
Q2
$7.65M Buy
14,268
+179
+1% +$85.6K 1.12% 29
2025
Q1
$5.92M Buy
14,089
+135
+1% +$58.6K 0.92% 37
2024
Q4
$5.77M Buy
13,954
+35
+0.3% +$15.4K 0.9% 37
2024
Q3
$7.03M Buy
13,919
+93
+0.7% +$45.2K 1.09% 30
2024
Q2
$6.74M Buy
13,826
+55
+0.4% +$27.6K 1.13% 30
2024
Q1
$7.44M Buy
13,771
+506
+4% +$277K 1.21% 29
2023
Q4
$7.36M Sell
13,265
-127
-0.9% -$59.6K 1.39% 21
2023
Q3
$5.86M Buy
13,392
+16
+0.1% +$7.98K 1.19% 31
2023
Q2
$6.72M Buy
13,376
+76
+0.6% +$36.4K 1.35% 28
2023
Q1
$6.65M Sell
13,300
-203
-2% -$97.1K 1.38% 27
2022
Q4
$5.51M Sell
13,503
-308
-2% -$120K 1.17% 29
2022
Q3
$4.5M Buy
13,811
+98
+0.7% +$36K 1.07% 34
2022
Q2
$4.81M Buy
13,713
+86
+0.6% +$35.1K 1.1% 36
2022
Q1
$7.46M Buy
13,627
+127
+0.9% +$66.8K 1.51% 17
2021
Q4
$8.89M Sell
13,500
-331
-2% -$208K 1.76% 12
2021
Q3
$8.6M Sell
13,831
-90
-0.6% -$60.5K 1.86% 10
2021
Q2
$8.79M Sell
13,921
-744
-5% -$411K 1.86% 9
2021
Q1
$7.18M Sell
14,665
-237
-2% -$119K 1.58% 19
2020
Q4
$7.45M Sell
14,902
-348
-2% -$156K 1.76% 10
2020
Q3
$6M Sell
15,250
-433
-3% -$160K 1.65% 16
2020
Q2
$5.18M Sell
15,683
-62
-0.4% -$18K 1.49% 21
2020
Q1
$3.81M Sell
15,745
-704
-4% -$184K 1.26% 31
2019
Q4
$4.29M Sell
16,449
-415
-2% -$109K 1.12% 38
2019
Q3
$4.58M Sell
16,864
-162
-1% -$45.1K 1.27% 34
2019
Q2
$4.69M Sell
17,026
-490
-3% -$121K 1.33% 29
2019
Q1
$3.92M Sell
17,516
-42
-0.2% -$8.67K 1.12% 37
2018
Q4
$3.27M Sell
17,558
-9
-0.1% -$1.84K 1.08% 40
2018
Q3
$4.38M Sell
17,567
-429
-2% -$104K 1.24% 31
2018
Q2
$3.92M Sell
17,996
-138
-0.8% -$28.4K 1.19% 34
2018
Q1
$3.47M Sell
18,134
-584
-3% -$108K 1.09% 39
2017
Q4
$2.93M Sell
18,718
-78
-0.4% -$12.3K 0.89% 47
2017
Q3
$2.92M Sell
18,796
-180
-0.9% -$28.5K 0.92% 48
2017
Q2
$3.06M Buy
18,976
+566
+3% +$91.9K 1.01% 43
2017
Q1
$2.85M Sell
18,410
-103
-0.6% -$14.2K 1.03% 44
2016
Q4
$2.17M Sell
18,513
-66
-0.4% -$7.53K 0.83% 47
2016
Q3
$2.09M Sell
18,579
-23,727
-56% -$2.5M 0.82% 49
2016
Q2
$3.93M Sell
42,306
-392
-0.9% -$33.7K 1.6% 21
2016
Q1
$3.34M Buy
42,698
+193
+0.5% +$13.9K 1.4% 30
2015
Q4
$3.1M Sell
42,505
-562
-1% -$40.1K 1.38% 35
2015
Q3
$3.2M Buy
43,067
+391
+0.9% +$28K 1.5% 29
2015
Q2
$2.74M Buy
42,676
+2,498
+6% +$173K 1.2% 41
2015
Q1
$3.1M Sell
40,178
-21,570
-35% -$1.68M 1.31% 37
2014
Q4
$4.58M Sell
61,748
-2,514
-4% -$176K 2.09% 6
2014
Q3
$3.79M Sell
64,262
-1,918
-3% -$121K 1.8% 15
2014
Q2
$4.42M Sell
66,180
-988
-1% -$62.8K 2.19% 9
2014
Q1
$4.08M Sell
67,168
-4,670
-7% -$278K 2.1% 9
2013
Q4
$3.82M Sell
71,838
-316
-0.4% -$16.6K 1.96% 14
2013
Q3
$3.6M Buy
72,154
+792
+1% +$38.1K 2.04% 9
2013
Q2
$3.2M Buy
+71,362
New +$3.12M 1.89% 14

Other funds holding IDXX

Cardinal Capital Management Inc (North Carolina)'s IDXX Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) increased its Idexx Laboratories (IDXX) stake by 0.31% in Q2 2026, buying an estimated $24.7K and bringing the position to 14,151 shares worth $7.45M. The position accounts for 0.9% of the portfolio, ranked #40.

Cardinal Capital Management Inc (North Carolina) first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.55M in Q4 2025. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Cardinal Capital Management Inc (North Carolina) held 14,151 shares of Idexx Laboratories worth $7.45M as of Q2 2026.
  • Cardinal Capital Management Inc (North Carolina) bought 44 Idexx Laboratories shares in Q2 2026, an estimated $24.7K.
  • Idexx Laboratories made up 0.9% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #40 holding.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Cardinal Capital Management Inc (North Carolina)'s Idexx Laboratories position peaked at $9.55M in Q4 2025.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.